Researchers probe genetic underpinnings of nicotine addiction

A new study from the Abramson Cancer Center and Department of Psychiatry in the University of Pennsylvania School of Medicine shows that smokers who carry a particular version of a gene for an enzyme that regulates dopamine in the brain may suffer from concentration problems and other cognitive deficits when abstaining from nicotine – a problem that puts them at risk for relapse during attempts to quit smoking. The findings, newly published in the journal Molecular Psychiatry, pave the way to identify novel medications to treat nicotine addiction.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news148063843.html">Researchers probe genetic underpinnings of nicotine addiction</a></p> <p>A new study from the Abramson Cancer Center and Department of Psychiatry in the University of Pennsylvania School of Medicine shows that smokers who carry a particular version of a gene for an enzyme that regulates dopamine in the brain may suffer from concentration problems and other cognitive deficits when abstaining from nicotine – a problem that puts them at risk for relapse during attempts to quit smoking. The findings, newly published in the journal <i>Molecular Psychiatry</i>, pave the way to identify novel medications to treat nicotine addiction. </p>